The usefulness of carcinoembryonic antigen in postoperative colorectal cancer patients

Diseases of the Colon and Rectum

Volumn 40, Issue 7, 1997, Pages 866-867

  Nelson, Richard L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

COLON TUMOR; FOLLOW UP; HUMAN; NOTE; PATHOLOGY; POSTOPERATIVE CARE; RECTUM TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RECTAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031178644     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/BF02055448     Document Type: Editorial

References (4)

1. Lucha PA Jr, Rosen L, Olenwine JA, et al Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum 1997;40:145-9-
2. Nelson RL. Screening of average-risk individuals for colorectal cancer and postoperative evaluation of patients with colorectal cancer. Surg Clin North Am 1996; 76:35-45.
3. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
4. Wagner JL, Behney CJ, Tunis SR, Ching A. Cost-effectiveness of colorectal cancer screening in average risk adults. Office of Technology Assessment. United States Congress. BP-H-146. April, 1995.